Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
This study is a real - world clinical research of adalimumab. The project plans to enroll 30 subjects, aiming to evaluat…
Guangzhou, ChinaEst. completion Mar 2029
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Psychological distress (PD) as a result of inflammatory bowel disease (IBD) is prevalent and associated with worse disea…
Halifax, CanadaEst. completion Mar 2027
Crohn DiseaseColitis, Ulcerative
Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medic…
Bristol, United StatesEst. completion Dec 17, 2037
Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with ada…
Dothan, United StatesEst. completion Jun 28, 2027
Crohn's Disease
The goal of this clinical trial is to learn whether a camera pill examination of the whole bowel can be used to diagnose…
Esbjerg, DenmarkEst. completion Aug 31, 2027
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United StatesEst. completion Oct 30, 2028
Crohn Disease
Crohn's disease (CD) develops because of a disruption of homeostasis between the gut microbiota and the host immune syst…
Minneapolis, United StatesEst. completion Jun 15, 2029
Crohn Disease
The main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089)…
Scottsdale, United StatesEst. completion Jun 2027
Colitis, UlcerativeCrohn Disease
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design component…
Scottsdale, United StatesEst. completion Jun 2027
Moderately to Severely Active Crohns Disease
This phase III, double-blind, multi-center treat-through study will evaluate the efficacy and safety of Afimkibart (also…
New York, United StatesEst. completion May 31, 2030
Fibrostenotic Crohn's Disease
This is an open, two-part study in healthy male volunteers, aged 30-65 years.
This trial aims to understand how the hum…
Nottingham, United KingdomEst. completion Sep 26, 2026
Crohn Disease (CD)
Crohn's disease is a condition of unknown etiology with an immune-mediated pathogenesis. The subgroup of Crohn's disease…
Roma, ItalyEst. completion Dec 31, 2026
Inflammatory Bowel DiseasesCrohn's Disease
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety o…
Lancaster, United StatesEst. completion Sep 2028
Crohn's DiseaseObesity or Overweight
The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizum…
Dothan, United StatesEst. completion May 2028
Crohn's DiseaseUlcerative Colitis
Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, se…
Dothan, United StatesEst. completion Oct 2031
Crohn Disease (CD)
The diagnosis of Crohn's Disease (CD) is based on a combination of clinical, biochemical (serological and fecal), endosc…
Brescia, ItalyEst. completion Dec 31, 2027
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system control…
Bethesda, United States
Crohn Disease (CD)
This research study is studying DB-3Q as a possible treatment for medically refractory Crohn's disease. The purpose of t…
St Louis, United StatesEst. completion Jun 2027
Crohn Disease (CD)Cryptoglandular Perianal Fistula
The goal of this study is to learn how well different imaging tests detect and describe perianal fistulas in adults with…
Hyderabad, IndiaEst. completion Apr 15, 2027
Inflammatory Bowel Disease (IBD)Crohn Disease (CD)Ulcerative Colitis (UC)IBD-unclassified (IBD-U)
The SHIFT-IBD Study is being conducted at multiple medical centers across Canada to evaluate how well guselkumab (Tremfy…
Calgary, CanadaEst. completion Nov 1, 2027